Objectives. We evaluated platelet counts in end-stage renal disease and chronic viral hepatitis.
Materials and Methods. We studied 70 patients with end-stage renal disease and chronic viral hepatitis and compared them to a control group of 45 patients without hepatitis.
Results. The presence of viral hepatitis was associated with a higher prevalence of thrombocytopenia. Correlations between age, C-reactive protein, liver stiffness measurement, and platelet count were observed. C-reactive protein levels > 10 mg/dl were associated with a lower risk of thrombocytopenia in patients with end-stage renal disease and chronic viral hepatitis, yet age > 60 years, dialysis vintage > 10 years, aspartate and alanine aminotransferase levels > 20 IU/L, albumin levels < 3.5 g/dl, and fibrosis stage ≥ 3 were not related.
Conclusions. Chronic viral hepatitis leads to a higher prevalence of thrombocytopenia. Platelet counts in these patients begin to decrease significantly once liver fibrosis reaches stage III.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Orasan, Olga Hilda; Urian, Laura; Ciulei, George; Breaban, Iulia; Stefan, Andreea Maria; Secara, Sorina Cezara; Sitar Taut, Adela; Tarmure Sarlea, Simina; Negrean, Vasile; Sampelean, Dorel; Patiu, Ioan Mihai; Orasan, Remus Aurel; and Cozma, Angela
"Thrombocytopenia in end-stage renal disease and chronic viral hepatitis B or C,"
Journal of Mind and Medical Sciences: Vol. 5
, Article 14.
Available at: https://scholar.valpo.edu/jmms/vol5/iss2/14